Fluxergy Platform

3446

Based on the PCB industry’s best practices for design and manufacturing, the Fluxergy Platform integrates multiple test technologies (molecular, immunochemistry, clinical chemistry, and cytology) within a single platform, enabling one platform to support rapid and cost-effective tests for all of the most common routine blood and infectious disease tests ordered. One device, endless possibilities.

Fluxergy is determined to be the first diagnostic company to effectively replace traditional lab testing with point-of-care (POC) testing through our multimodal Fluxergy Platform. Access to POC testing can significantly impact the quality of care provided by clinicians, especially in decentralized and lower-resource healthcare settings. Adoption of current POC platforms has been limited by their high instrument and test costs; concerns about non-laboratory personnel accurately and reproducibly performing this mode of testing; and the modality limitations of current POC platforms being able to run only one type of testing. The Fluxergy Platform overcomes these limitations by combining the test modalities (molecular, immunochemistry, clinical chemistry, and cytology) required to perform the most common blood and infectious disease tests into a single card. Fluxergy will be able to equip healthcare providers with one device for all common test orders at an affordable price point.

fluxergy-platformsm.png

fluxergy-platformlg.png